INSIGHTS ON CELL & GENE MANUFACTURING AND LOGISTICS

• Navigating Regulatory Shifts: EU GMP Annex 1 And USP 382

  Strengthen risk mitigation strategies while ensuring regulatory alignment. Gain valuable insights into best practices and proactive approaches for building a robust and future-ready CCS.

• How Modeling Predicts Bottlenecks In Takeda's Multimodal Facilities

  A functional simulation requires many manual inputs, including data smoothing, vendor collaboration, and even direct communication with tenured employees who know the job best.

• Ferring Builds A Global Gene Therapy Manufacturing Network Around ADSTILADRIN

  Ferring Pharmaceuticals has built a global manufacturing and support network around its flagship gene therapy, ADSTILADRIN, enabling scalable production, provider education, patient access, and real-world data collection to ensure sustainable and widespread adoption.

• Good Distribution Practice Is Evolving — Here's How

  Managing a global supply chain for increasingly complex biologic drugs takes special attention and expertise. Explore the key drivers of a modern logistics management plan.

• Unlocking Flexible AAV Production With In-House Plasmids, Manufacturing Capacity

  Discover how 3PBIOVIAN’s advanced plasmid manufacturing and AAVion® platform can drive your AAV program forward by reducing production costs while maximizing efficiency.

• The Future Of QC: Robotics And Automation

  See how pharma 4.0 is revolutionizing the pharmaceutical industry with automation and digitalization to transform microbiological quality control labs into efficient, real-time-monitored environments that enhance productivity.

• CHO Cell Culture Solutions For Biomanufacturing

  Improve your biopharmaceutical manufacturing performance with high-performance CHO media, feeds, supplements, cell line development kits, and media manufacturing and optimizing services.

• 21st Century Manufacturing Of Injectable Pharmaceuticals

  Discover how rising competition, niche patient populations, and evolving therapies are reshaping sterile injectable drug development with cutting-edge technologies.

• A Shift Towards Biofluorescent Particle Counters In Manufacturing

  Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.

• Continuing Your Research Mission -- Even As Budgets Tighten

  Amid growing uncertainty in clinical research funding, including proposed budget cuts from the NIH that threaten indirect support for essential infrastructure, OpenClinica remains a steadfast partner to researchers.